Becton Dickinson and Co. (BDX) Forecasted to Post FY2018 Earnings of $10.52 Per Share
Becton Dickinson and Co. (NYSE:BDX) – Investment analysts at Leerink Swann raised their FY2018 earnings estimates for Becton Dickinson and in a research report issued on Thursday. Leerink Swann analyst R. Newitter now expects that the firm will earn $10.52 per share for the year, up from their prior forecast of $10.42. Leerink Swann currently has a “Hold” rating on the stock. Leerink Swann also issued estimates for Becton Dickinson and’s FY2019 earnings at $11.58 EPS.
Several other analysts also recently commented on the stock. Zacks Investment Research downgraded shares of Becton Dickinson and from a “buy” rating to a “hold” rating in a research report on Wednesday, November 16th. Deutsche Bank AG reiterated a “buy” rating and issued a $189.00 price target (down from $197.00) on shares of Becton Dickinson and in a report on Friday, November 4th. Argus reiterated a “buy” rating and issued a $185.00 price target on shares of Becton Dickinson and in a report on Friday, October 21st. Citigroup Inc. downgraded shares of Becton Dickinson and from a “neutral” rating to a “sell” rating and reduced their price target for the company from $167.00 to $165.00 in a report on Friday, September 23rd. Finally, Cowen and Company reiterated an “outperform” rating and issued a $185.00 price target on shares of Becton Dickinson and in a report on Tuesday, August 16th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $175.39.
Shares of Becton Dickinson and (NYSE:BDX) opened at 171.86 on Monday. Becton Dickinson and has a 12-month low of $129.50 and a 12-month high of $181.76. The stock has a market capitalization of $36.59 billion, a price-to-earnings ratio of 38.28 and a beta of 1.04. The stock’s 50 day moving average is $172.67 and its 200-day moving average is $172.12.
Becton Dickinson and (NYSE:BDX) last posted its earnings results on Thursday, November 3rd. The company reported $2.12 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.09 by $0.03. The company earned $3.23 billion during the quarter, compared to analyst estimates of $3.22 billion. Becton Dickinson and had a net margin of 7.82% and a return on equity of 24.44%. Becton Dickinson and’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.94 earnings per share.
In other Becton Dickinson and news, insider Stephen Sichak sold 10,352 shares of the company’s stock in a transaction dated Friday, November 4th. The shares were sold at an average price of $176.10, for a total value of $1,822,987.20. Following the transaction, the insider now directly owns 26,892 shares in the company, valued at approximately $4,735,681.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Linda M. Tharby sold 11,704 shares of the company’s stock in a transaction dated Tuesday, September 6th. The stock was sold at an average price of $177.27, for a total transaction of $2,074,768.08. Following the completion of the transaction, the insider now owns 22,146 shares in the company, valued at $3,925,821.42. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.
A number of institutional investors have recently modified their holdings of BDX. Jarislowsky Fraser Ltd increased its position in Becton Dickinson and by 1,050.3% in the second quarter. Jarislowsky Fraser Ltd now owns 10,373,430 shares of the company’s stock worth $531,241,000 after buying an additional 9,471,594 shares in the last quarter. JPMorgan Chase & Co. increased its position in Becton Dickinson and by 64.3% in the second quarter. JPMorgan Chase & Co. now owns 3,779,957 shares of the company’s stock worth $641,043,000 after buying an additional 1,479,124 shares in the last quarter. Bank of Montreal Can increased its position in Becton Dickinson and by 128.9% in the third quarter. Bank of Montreal Can now owns 1,602,619 shares of the company’s stock worth $288,037,000 after buying an additional 902,427 shares in the last quarter. Prudential Financial Inc. increased its position in Becton Dickinson and by 278.3% in the second quarter. Prudential Financial Inc. now owns 1,029,329 shares of the company’s stock worth $174,563,000 after buying an additional 757,251 shares in the last quarter. Finally, Emerald Acquisition Ltd. acquired a new position in Becton Dickinson and during the second quarter worth about $102,860,000. Institutional investors and hedge funds own 82.68% of the company’s stock.
Becton Dickinson and Company Profile
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
Receive News & Stock Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related stocks with our FREE daily email newsletter.